QCDx
Connecticut, United States · Biotechnology, Health Care, Medical · 9 employees
QCDx, Inc. is a privately held diagnostics innovator at the forefront of precision oncology. The company develops proprietary liquid biopsy technologies for the enrichment-free detection and proteomic profiling of circulating tumor cells (CTCs), empowering oncologists with real-time insights into tumor heterogeneity, therapeutic targets, and disease progression. Founded by Dr. Triantafyllos Tafas,
Funding history
- Funding Round — $7.0M — May 2025
Recent signals
- May 01, 2025: Raised $7.0M
See plans & pricing → Track QCDx’s funding, hiring, and signals — with verified contacts — on Fundz.